Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01035333 · ClinicalTrials.gov registry record · Phase 4
A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.
A Phase 4 study, sponsored by Albany College of Pharmacy and Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT01035333 is a Phase 4 study that has completed, run by Albany College of Pharmacy and Health Sciences. The registered enrollment target is 19 participants.
The verdict
NCT01035333, a Phase 4 study, has completed, sponsored by Albany College of Pharmacy and Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.
Interventions
- DRUG Orlistat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01035333
The ClinicalTrials.gov registry entry for NCT01035333 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany College of Pharmacy and Health Sciences, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Orlistat is the first listed.
NCT01035333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01035333 about?
NCT01035333 is a clinical study titled "A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.". The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meeti...
What is the current status of trial NCT01035333?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2009-11. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01035333?
The interventions under investigation include: Orlistat (DRUG).
Who is sponsoring clinical trial NCT01035333?
This trial is sponsored by Albany College of Pharmacy and Health Sciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.